Close Menu
    What's Hot
    Lane Clark & Peacock

    2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

    March 30, 2026
    Just Group

    Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

    March 30, 2026

    Athora Group Completes Acquisition of Pension Insurance Corporation

    March 30, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      US Individual Life Insurance New Premium To Set New Sales Record in 2025

      March 4, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Panasonic UK Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

      March 25, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

      February 11, 2026

      Q&A: Brandon Marz, Co-Founder and Chief Strategy Officer, LifeRoc Capital

      March 25, 2026

      Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

      March 11, 2026

      Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

      March 11, 2026

      Kosmos Management Announces Seventh Asset-Backed Securitisation

      March 5, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Panasonic UK Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

      March 25, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Life Insurance Companies Continue To Offer Opportunities for Private Debt Despite Macro Uncertainty

    Life Insurance November 16, 2022By Greg Winterton
    Life insurance private debt
    Share
    Twitter LinkedIn Email

    High inflation, the spectre of a recession and an increase in the cost of borrowing could put pressure on many SMEs that have taken out floating rate loans from private debt shops or that are looking to restructure existing debt or take out additional loans in the coming twelve to 24 months. It’s an industry wide challenge that the private debt sector – by far the largest subset of the alternative credit market – will face in the short term.

    Some of the nuances of the life insurance industry may provide some kind of insulation from the coming storm. Life insurance companies tend to make more money in a rising interest rate environment because the premiums received from any new business they underwrite can be allocated to higher yielding investments; ergo, they are healthier counterparties for investors and lenders.

    Despite this benefit, however, this subset of the direct lending market remains an under resourced one. Dan Knipe, Founder and CIO of speciality lender and KKR portfolio company Kilter Finance, says that there is a perception issue amongst investors that is a touch misguided.

    “Investors tend to only see a handful of household names. This larger end of the insurance lending market is very efficient from a capital markets perspective as the issuers are generally listed and can tap the debt capital markets when they need to,” he said. “But below that, it’s super inefficient because private lending is out of scope for the investors in the large public bonds and traditional private lenders don’t have the familiarity with the balance sheet side of the insurance sector. When you look at the amount of capital across European and US life insurers, there’s in excess of $1.5trn worth of capital and surplus. The tail of potential borrowers for private debt solutions is really long.”

    Part of the reason that the insurance sector is less well served by private debt than, say, the manufacturing industry might be is because of the comparatively higher level of complication of the respective companies. Lenders to manufacturing or retail businesses, for example, understand where the revenue comes from, and they have a good sense of what needs to be done to engineer a recovery, if necessary. But life insurance companies are complicated businesses with additional layers of complexity.

    “A life insurer’s balance sheet is very large and materially different to businesses whose revenues are derived from the provision of services for a fee. It’s a heavily regulated sector, so debt underwriting, debt management and any debt workout requires specific and specialised experience and skills,” said Knipe. “Private debt markets are available to insurance services businesses that don’t need large balance sheets. For life insurers who have a material balance sheet the presence of complex regulatory, rating and accounting interactions opens up an interesting opportunity to earn excess returns as compared to lending to simpler businesses.”

    Investors looking at the life insurance sector as an alpha generator should also need to drill down on the differences in exposure to life and non-life carriers as Luca Tres, Head of EMEA Strategic Risk and Capital Life Solutions at Guy Carpenter, explains.

    “On the life side, catastrophe risk tends to be fairly limited (we witnessed this during the Covid-19 pandemic), but the asset risk component is usually more prominent than for property and casualty carriers because of the longer duration of the life insurance liabilities and the savings components that many life insurance policies have. Also, it’s very different to lend to a life insurance company with a traditional risk product mix and a conservative investment portfolio. And the jurisdiction of the borrower can have an important role itself, since capital requirements, investment and risk guidelines can be different.”

    Additionally, the wide range of debt financing opportunities in the life insurance market – reinsurance-based financing, senior bonds/loans, Tier 2 financing, RT1 financing, etc. – need to have the risk exposure analysed and understood.

    “These are all insurance lending structures, but the risk can differ materially depending on the type of financing. Also, insurance holding company financing versus financing a transaction at the operating company again has a different risk profile,” said Tres. “Insurance lending provides different risk/reward profiles suited to different investors’ needs in different parts of the credit cycle, so every situation needs to be analysed on a case-by-case basis.”

    Investors look to credit investing as a lower volatility yield generator that serves as a diversifier to public and private equity exposure. Tres says that in times of economic uncertainty, life insurance companies can provide a defensive element, too.

    “Lending to highly regulated businesses like life insurance companies can make a material difference compared to non-regulated businesses. While one could argue that asset risk is one of the largest risks (especially in a volatile macroeconomic context) for insurance companies, in a stressed context, the regulation that insurers are forced to comply with by definition puts lenders in a better position compared to many other industries. In Europe for example, Solvency II forces insurance companies to have capital covering the 99.5% worst case scenario; if you exclude insurance and banking activities – where do you see anything that’s comparable?”

    For Knipe, those potentially interested in accessing the life insurance space for fixed income returns need to get comfortable with the potential correlation of returns in the space to the broader fixed income and equity markets, but he agrees that the regulatory situation can act as a defensive support and urges investors to take more notice.

    “You can’t say that there is a zero correlation between life insurance companies and financial markets – there is always some level of correlation,” said Knipe. “But the regulatory framework tends to isolate an investment in a life insurer from many of the cyclical impacts you might see in other sectors. We’d encourage investors to take some time to understand the large opportunity set in the space. It’s an opportunity to access a diversifying return stream to complement a broader private credit portfolio.”

    2022 - November Alternative Credit Volume 1 Issue 7 - November 2022
    Share. Twitter LinkedIn Email

    Related Posts

    EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

    March 25, 2026By Greg Winterton

    Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

    January 28, 2026By Greg Winterton

    Q&A: Chris Wells, Managing Editor, Longevity and Mortality Investor

    October 8, 2025By Greg Winterton

    Generali Investments Completes Acquisition of Majority Stake in MGG Investment Group

    October 2, 2025By LMI Newsdesk
    Latest Issue

    Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

    March 11, 2026

    Longevity Swap Activity Expected to Rise as Run-Ons Look More Attractive

    March 11, 2026

    Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

    March 11, 2026

    Defined Benefit Pension Fund Investment Strategies in Focus Amid Gilts-Linked Pension Risk Transfer Pricing

    February 25, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.